CAW
IMGN

Cornerstone Advisors (Washington)’s Immunogen Inc IMGN Stock Holding History

Cornerstone Advisors (Washington)’s Portfolio IMGN Stock Details IMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-250
Closed -$2K – 1296
2018
Q3 		$2K Hold
250
– – ﹤0.01% 918
2018
Q2 		$2K Hold
250
– – ﹤0.01% 883
2018
Q1 		$3K Hold
250
– – ﹤0.01% 792
2017
Q4 		$2K Hold
250
– – ﹤0.01% 829
2017
Q3 		$2K Buy
+250
New +$1.66K ﹤0.01% 827

Other funds holding IMGN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Cornerstone Advisors (Washington)'s IMGN Position: Q4 2018 in Review

Cornerstone Advisors (Washington) sold out of Immunogen Inc (IMGN) in Q4 2018, closing a stake of 250 shares — an estimated $2K sold.

Cornerstone Advisors (Washington) first reported a position in IMGN in Q3 2017 and held it in 5 quarters. The position peaked at $3K in Q1 2018. 200 funds tracked by Wall St. Rank hold IMGN as of Q4 2018.

  • Cornerstone Advisors (Washington) reported no remaining Immunogen Inc position as of Q4 2018 after selling out during the quarter.
  • Cornerstone Advisors (Washington) sold 250 Immunogen Inc shares in Q4 2018, an estimated $2K.
  • Cornerstone Advisors (Washington) first reported a position in Immunogen Inc in Q3 2017 and held it in 5 quarters.
  • Cornerstone Advisors (Washington)'s Immunogen Inc position peaked at $3K in Q1 2018.
  • 200 funds tracked by Wall St. Rank held Immunogen Inc as of Q4 2018.

Based on Cornerstone Advisors (Washington)'s 13F filing for Q4 2018, filed 16 Jan 2019.